160 related articles for article (PubMed ID: 34252213)
1. Symptom trajectories for palliative care inpatients with and without hyperactive delirium in the last week of life.
Dai Y; Walpole G; Ding J; Scanlon C; Ho L; Khoo RH; Huang C; Cook A; William L; Johnson CE
J Adv Nurs; 2022 Jan; 78(1):142-153. PubMed ID: 34252213
[TBL] [Abstract][Full Text] [Related]
2. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care.
Spiller JA; Keen JC
Palliat Med; 2006 Jan; 20(1):17-23. PubMed ID: 16482754
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prevalence and associated factors of hyperactive delirium in advanced cancer patients between inpatient palliative care and palliative home care.
Hamano J; Mori M; Ozawa T; Sasaki J; Kawahara M; Nakamura A; Hashimoto K; Hisajima K; Koga T; Goto K; Fukumoto K; Morimoto Y; Goshima M; Sekimoto G; Baba M; Oya K; Matsunuma R; Azuma Y; Imai K; Morita T; Shinjo T
Cancer Med; 2021 Feb; 10(3):1166-1179. PubMed ID: 33314743
[TBL] [Abstract][Full Text] [Related]
5. Refractory hyperactive delirium in the dying: pharmacological management.
Tham K; Shiu A; William L; Walpole G; Rashed S
BMJ Support Palliat Care; 2022 Dec; 12(4):471-474. PubMed ID: 34819327
[TBL] [Abstract][Full Text] [Related]
6. Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.
Mercadante S; Adile C; Ferrera P; Cortegiani A; Casuccio A
Oncologist; 2019 Jun; 24(6):e358-e364. PubMed ID: 30355776
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of People with Dementia vs Other Conditions on Admission to Inpatient Palliative Care.
Ding J; Johnson CE; Lee YCO; Gazey A; Cook A
J Am Geriatr Soc; 2020 Aug; 68(8):1825-1833. PubMed ID: 32329901
[TBL] [Abstract][Full Text] [Related]
8. The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center.
de la Cruz M; Fan J; Yennu S; Tanco K; Shin S; Wu J; Liu D; Bruera E
Support Care Cancer; 2015 Aug; 23(8):2427-33. PubMed ID: 25617070
[TBL] [Abstract][Full Text] [Related]
9. Chlorpromazine's Potential Role in Palliating Distressing Symptoms Associated With Hyperactive Delirium in Patients at End of Life.
Tiefenthaler CM; Hirst JM; Edmonds KP; Atayee RS
J Palliat Med; 2023 Jun; 26(6):826-830. PubMed ID: 36847737
[No Abstract] [Full Text] [Related]
10. Measuring delirium point-prevalence in two Australian palliative care inpatient units.
Hosie A; Lobb E; Agar M; Davidson P; Chye R; Lam L; Phillips J
Int J Palliat Nurs; 2016 Jan; 22(1):13-21. PubMed ID: 26804952
[TBL] [Abstract][Full Text] [Related]
11. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review.
Hosie A; Davidson PM; Agar M; Sanderson CR; Phillips J
Palliat Med; 2013 Jun; 27(6):486-98. PubMed ID: 22988044
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Delirium in End-of-Life Palliative Care Patients: An Observational Study.
Recchia A; Rizzi B; Favero A; Nobili A; Pasina L
Med Princ Pract; 2022; 31(2):118-124. PubMed ID: 35038708
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant use and hyperactive delirium at the end of life: retrospective study.
Gleadle N; Cook A; Johnson CE; Walpole G
BMJ Support Palliat Care; 2024 Jan; 13(e3):e916-e919. PubMed ID: 37479249
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural adaptation and psychometric validation of point-of-care outcome assessment tools in Chinese palliative care clinical practice.
Dai Y; Johnson CE; Ding J; Chen Y; Connolly A; Wang L; Daveson BA
BMC Palliat Care; 2024 Apr; 23(1):89. PubMed ID: 38566178
[TBL] [Abstract][Full Text] [Related]
15. Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study.
Hosie A; Lobb E; Agar M; Davidson PM; Chye R; Phillips J
J Clin Nurs; 2015 Nov; 24(21-22):3276-85. PubMed ID: 26249026
[TBL] [Abstract][Full Text] [Related]
16. Increasing anticholinergic burden and delirium in palliative care inpatients.
Zimmerman KM; Salow M; Skarf LM; Kostas T; Paquin A; Simone MJ; Rudolph J
Palliat Med; 2014 Apr; 28(4):335-41. PubMed ID: 24534725
[TBL] [Abstract][Full Text] [Related]
17. Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care.
Lim KH; Nguyen NN; Qian Y; Williams JL; Lui DD; Bruera E; Yennurajalingam S
J Palliat Med; 2018 Dec; 21(12):1698-1704. PubMed ID: 30260731
[No Abstract] [Full Text] [Related]
18. Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey.
Fang CK; Chen HW; Liu SI; Lin CJ; Tsai LY; Lai YL
Jpn J Clin Oncol; 2008 Jan; 38(1):56-63. PubMed ID: 18238881
[TBL] [Abstract][Full Text] [Related]
19. Differences in Symptom Distress Based on Gender and Palliative Care Designation Among Hospitalized Patients.
Falk H; Henoch I; Ozanne A; Öhlen J; Ung EJ; Fridh I; Sarenmalm EK; Falk K
J Nurs Scholarsh; 2016 Nov; 48(6):569-576. PubMed ID: 27668982
[TBL] [Abstract][Full Text] [Related]
20. Increased Symptom Expression among Patients with Delirium Admitted to an Acute Palliative Care Unit.
de la Cruz M; Yennu S; Liu D; Wu J; Reddy A; Bruera E
J Palliat Med; 2017 Jun; 20(6):638-641. PubMed ID: 28157431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
